Opioid use prior to knee arthroplasty in patients who catastrophize about their pain

Preoperative data from a multisite randomized clinical trial

Daniel L. Riddle, James D. Slover, Dennis C. Ang, Matthew Bair, Kurt Kroenke, Robert A. Perera, Levent Dumenci

Research output: Contribution to journalArticle

Abstract

Background: Opioid use rates prior to knee arthroplasty (KA) among people who catastrophize about their pain are unknown. We determined prevalence of opioid use and compared patterns of preoperative opioid use and oral morphine equivalent (OME), a measure of daily opioid dose, across varied geographic sites. We also determined which baseline variables were associated with opioid use and OME. Patients and methods: Preoperative opioid use data described type of opioid, dosage, and frequency among 397 patients scheduled for KA. Demographic, knee-related pain, and psychological distress dimensions were examined to identify variables associated with opioid use and opioid dose (OME). Opioid use prevalence and OME were compared across the four sites. A three-level censored regression determined variables associated with opioid use and OME. Results: The overall opioid use prevalence was 31.7% (95% confidence interval [CI] = 27.0, 36.3) and varied across sites from 15.9% (95% CI = 9.0, 22.8) to 51.2% (95% CI = 40.5, 61.9). After adjustment, patients using opioids were more likely to be younger, African American, and have higher self-efficacy and comorbidity scores (P < 0.05). The only variable independently associated with OME was lower depressive symptoms (P < 0.05). Conclusion: People who catastrophized prior to KA did not demonstrate increased preoperative opioid use based on current evidence, but variation in the prevalence of opioid use across study sites was substantial. Variables associated with opioid use were non-modifiable demographic and comorbidity variables.

Original languageEnglish (US)
Pages (from-to)1549-1557
Number of pages9
JournalJournal of Pain Research
Volume11
DOIs
StatePublished - Jan 1 2018

Fingerprint

Catastrophization
Knee Replacement Arthroplasties
Opioid Analgesics
Randomized Controlled Trials
Pain
Morphine
Confidence Intervals
Comorbidity
Demography
Social Adjustment

Keywords

  • Arthroplasty
  • Catastrophizing
  • Knee
  • Opioid
  • Pain

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Opioid use prior to knee arthroplasty in patients who catastrophize about their pain : Preoperative data from a multisite randomized clinical trial. / Riddle, Daniel L.; Slover, James D.; Ang, Dennis C.; Bair, Matthew; Kroenke, Kurt; Perera, Robert A.; Dumenci, Levent.

In: Journal of Pain Research, Vol. 11, 01.01.2018, p. 1549-1557.

Research output: Contribution to journalArticle

@article{68eddd580b96442b9be25c3ee08f757b,
title = "Opioid use prior to knee arthroplasty in patients who catastrophize about their pain: Preoperative data from a multisite randomized clinical trial",
abstract = "Background: Opioid use rates prior to knee arthroplasty (KA) among people who catastrophize about their pain are unknown. We determined prevalence of opioid use and compared patterns of preoperative opioid use and oral morphine equivalent (OME), a measure of daily opioid dose, across varied geographic sites. We also determined which baseline variables were associated with opioid use and OME. Patients and methods: Preoperative opioid use data described type of opioid, dosage, and frequency among 397 patients scheduled for KA. Demographic, knee-related pain, and psychological distress dimensions were examined to identify variables associated with opioid use and opioid dose (OME). Opioid use prevalence and OME were compared across the four sites. A three-level censored regression determined variables associated with opioid use and OME. Results: The overall opioid use prevalence was 31.7{\%} (95{\%} confidence interval [CI] = 27.0, 36.3) and varied across sites from 15.9{\%} (95{\%} CI = 9.0, 22.8) to 51.2{\%} (95{\%} CI = 40.5, 61.9). After adjustment, patients using opioids were more likely to be younger, African American, and have higher self-efficacy and comorbidity scores (P < 0.05). The only variable independently associated with OME was lower depressive symptoms (P < 0.05). Conclusion: People who catastrophized prior to KA did not demonstrate increased preoperative opioid use based on current evidence, but variation in the prevalence of opioid use across study sites was substantial. Variables associated with opioid use were non-modifiable demographic and comorbidity variables.",
keywords = "Arthroplasty, Catastrophizing, Knee, Opioid, Pain",
author = "Riddle, {Daniel L.} and Slover, {James D.} and Ang, {Dennis C.} and Matthew Bair and Kurt Kroenke and Perera, {Robert A.} and Levent Dumenci",
year = "2018",
month = "1",
day = "1",
doi = "10.2147/JPR.S168251",
language = "English (US)",
volume = "11",
pages = "1549--1557",
journal = "Journal of Pain Research",
issn = "1178-7090",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - Opioid use prior to knee arthroplasty in patients who catastrophize about their pain

T2 - Preoperative data from a multisite randomized clinical trial

AU - Riddle, Daniel L.

AU - Slover, James D.

AU - Ang, Dennis C.

AU - Bair, Matthew

AU - Kroenke, Kurt

AU - Perera, Robert A.

AU - Dumenci, Levent

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: Opioid use rates prior to knee arthroplasty (KA) among people who catastrophize about their pain are unknown. We determined prevalence of opioid use and compared patterns of preoperative opioid use and oral morphine equivalent (OME), a measure of daily opioid dose, across varied geographic sites. We also determined which baseline variables were associated with opioid use and OME. Patients and methods: Preoperative opioid use data described type of opioid, dosage, and frequency among 397 patients scheduled for KA. Demographic, knee-related pain, and psychological distress dimensions were examined to identify variables associated with opioid use and opioid dose (OME). Opioid use prevalence and OME were compared across the four sites. A three-level censored regression determined variables associated with opioid use and OME. Results: The overall opioid use prevalence was 31.7% (95% confidence interval [CI] = 27.0, 36.3) and varied across sites from 15.9% (95% CI = 9.0, 22.8) to 51.2% (95% CI = 40.5, 61.9). After adjustment, patients using opioids were more likely to be younger, African American, and have higher self-efficacy and comorbidity scores (P < 0.05). The only variable independently associated with OME was lower depressive symptoms (P < 0.05). Conclusion: People who catastrophized prior to KA did not demonstrate increased preoperative opioid use based on current evidence, but variation in the prevalence of opioid use across study sites was substantial. Variables associated with opioid use were non-modifiable demographic and comorbidity variables.

AB - Background: Opioid use rates prior to knee arthroplasty (KA) among people who catastrophize about their pain are unknown. We determined prevalence of opioid use and compared patterns of preoperative opioid use and oral morphine equivalent (OME), a measure of daily opioid dose, across varied geographic sites. We also determined which baseline variables were associated with opioid use and OME. Patients and methods: Preoperative opioid use data described type of opioid, dosage, and frequency among 397 patients scheduled for KA. Demographic, knee-related pain, and psychological distress dimensions were examined to identify variables associated with opioid use and opioid dose (OME). Opioid use prevalence and OME were compared across the four sites. A three-level censored regression determined variables associated with opioid use and OME. Results: The overall opioid use prevalence was 31.7% (95% confidence interval [CI] = 27.0, 36.3) and varied across sites from 15.9% (95% CI = 9.0, 22.8) to 51.2% (95% CI = 40.5, 61.9). After adjustment, patients using opioids were more likely to be younger, African American, and have higher self-efficacy and comorbidity scores (P < 0.05). The only variable independently associated with OME was lower depressive symptoms (P < 0.05). Conclusion: People who catastrophized prior to KA did not demonstrate increased preoperative opioid use based on current evidence, but variation in the prevalence of opioid use across study sites was substantial. Variables associated with opioid use were non-modifiable demographic and comorbidity variables.

KW - Arthroplasty

KW - Catastrophizing

KW - Knee

KW - Opioid

KW - Pain

UR - http://www.scopus.com/inward/record.url?scp=85058809910&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058809910&partnerID=8YFLogxK

U2 - 10.2147/JPR.S168251

DO - 10.2147/JPR.S168251

M3 - Article

VL - 11

SP - 1549

EP - 1557

JO - Journal of Pain Research

JF - Journal of Pain Research

SN - 1178-7090

ER -